Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Combined antimalarial therapy using artemisinin].

G Majori1

  • 1Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, WHO Collaborating Centre for Research and Training in Tropical Diseases Control, Roma.

Parassitologia
|August 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An overview of the lesson learned in almost 20 years of fight against the "tiger" mosquito.

Parassitologia·2008
Same author

The role of research in the fight against malaria: the Italian contribution to malaria research in the frame of north-south cooperation in the last 25 years.

Parassitologia·2008
Same author

Chikungunya in north-eastern Italy: a summing up of the outbreak.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2007
Same author

An outbreak of chikungunya fever in the province of Ravenna, Italy.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2007
Same author

Malaria surveillance in Italy : 1986-1996 analysis and 1997 provisional data.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2003
Same author

Malaria surveillance in Italy: 1997 analysis and 1998 provisional data.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2003

Antimalarial drug resistance necessitates combination therapies, particularly artemisinin-based combination therapies (ACTs), to improve efficacy and delay resistance. Challenges in ACT deployment in Africa require strategic implementation for effective malaria control.

Area of Science:

  • Tropical Medicine
  • Pharmacology
  • Infectious Diseases

Background:

  • Limited antimalarial drugs due to resistance necessitates innovative treatment strategies.
  • Drug resistance and cross-resistance significantly reduce the efficacy of existing antimalarial monotherapies.
  • The global prevalence of malaria, particularly in developing nations, demands affordable and sustainable treatment options.

Purpose of the Study:

  • To review the role of combination therapy (CT) in combating antimalarial drug resistance.
  • To highlight the advantages and challenges of implementing antimalarial CT, especially artemisinin-based combination therapies (ACTs).
  • To discuss WHO-recommended therapeutic options for malaria treatment in the context of evolving drug resistance.

Main Methods:

Related Experiment Videos

  • Literature review of antimalarial drug resistance and combination therapy principles.
  • Analysis of World Health Organization (WHO) recommendations on antimalarial treatment guidelines.
  • Examination of the pharmacodynamic and pharmacokinetic properties influencing rational drug combinations.
  • Main Results:

    • Artemisinin-based combination therapies (ACTs) demonstrate improved efficacy and resistance containment in Southeast Asia.
    • Significant challenges hinder ACT deployment in Africa, including cost, optimal drug selection, and operational compliance.
    • WHO recommends ACTs for Plasmodium falciparum malaria where resistance to conventional monotherapies is prevalent.

    Conclusions:

    • Combination therapy, particularly ACTs, is crucial for effective malaria treatment and resistance management.
    • Addressing implementation challenges is vital for successful ACT deployment, especially in high-burden regions like Africa.
    • Continued research and development of affordable antimalarial drugs are essential for long-term malaria control.